Verve Therapeutics (NASDAQ:VERV – Get Free Report) was upgraded by analysts at Wall Street Zen to a “hold” rating in a report issued on Saturday. A number of other brokerages also recently weighed in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results